Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REGAIN: Propofol vs Desflurane in Nephrectomy
NCT04447105Completed
- Sponsor
- Seoul National University Hospital
- Start
- Jun 2020
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of propofol injection (veterinary) in kidney cancer (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Quality of Recovery-15K at 72 hours. Started Jun 2020; status: completed.
02
Drugs
propofol injection (veterinary)
03
Conditions
kidney cancer
Beyond the preview
Go deeper on NCT04447105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04447105.